PortfoliosLab logoPortfoliosLab logo
PBE vs. VHT
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

PBE vs. VHT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Dynamic Biotechnology & Genome ETF (PBE) and Vanguard Health Care ETF (VHT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, PBE achieves a 0.58% return, which is significantly higher than VHT's -4.02% return. Over the past 10 years, PBE has underperformed VHT with an annualized return of 7.55%, while VHT has yielded a comparatively higher 9.26% annualized return.


PBE

1D
2.04%
1M
2.68%
YTD
0.58%
6M
1.15%
1Y
30.26%
3Y*
10.44%
5Y*
3.06%
10Y*
7.55%

VHT

1D
0.84%
1M
1.45%
YTD
-4.02%
6M
-4.15%
1Y
14.34%
3Y*
6.14%
5Y*
4.51%
10Y*
9.26%
*Multi-year figures are annualized to reflect compound growth (CAGR)

PBE vs. VHT - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
PBE
Invesco Dynamic Biotechnology & Genome ETF
0.58%24.84%1.10%3.71%-10.83%1.54%25.66%18.65%-0.19%22.28%
VHT
Vanguard Health Care ETF
-4.02%15.46%2.66%2.52%-5.60%20.57%18.29%21.87%5.58%23.26%

Correlation

The correlation between PBE and VHT is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.78

Correlation (3Y)
Calculated over the trailing 3-year period

0.74

Correlation (5Y)
Calculated over the trailing 5-year period

0.76

Correlation (10Y)
Calculated over the trailing 10-year period

0.77

Correlation (All Time)
Calculated using the full available price history since Jun 24, 2005

0.79

The correlation between PBE and VHT has been stable across timeframes, ranging from 0.74 to 0.79 - a consistent structural relationship.

PBE vs. VHT - Sectors Allocation Comparison


Sectors
PBE
VHT

Healthcare

100.0%
100.0%

Financial Services

0.0%
0.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Industrials

-

0.0%

Real Estate

-

-

Technology

-

0.0%

Utilities

-

-

Healthcare

PBE
100.0%
VHT
100.0%

Financial Services

PBE
0.0%
VHT
0.0%

Basic Materials

PBE

-

VHT

-

Communication Services

PBE

-

VHT

-

Consumer Cyclical

PBE

-

VHT

-

Consumer Defensive

PBE

-

VHT

-

Energy

PBE

-

VHT

-

Industrials

PBE

-

VHT
0.0%

Real Estate

PBE

-

VHT

-

Technology

PBE

-

VHT
0.0%

Utilities

PBE

-

VHT

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

PBE vs. VHT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

PBE
PBE Risk / Return Rank: 4747
Overall Rank
PBE Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
PBE Sortino Ratio Rank: 4949
Sortino Ratio Rank
PBE Omega Ratio Rank: 4444
Omega Ratio Rank
PBE Calmar Ratio Rank: 5252
Calmar Ratio Rank
PBE Martin Ratio Rank: 4444
Martin Ratio Rank

VHT
VHT Risk / Return Rank: 2727
Overall Rank
VHT Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
VHT Sortino Ratio Rank: 2828
Sortino Ratio Rank
VHT Omega Ratio Rank: 2626
Omega Ratio Rank
VHT Calmar Ratio Rank: 2828
Calmar Ratio Rank
VHT Martin Ratio Rank: 2525
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

PBE vs. VHT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and Vanguard Health Care ETF (VHT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


PBEVHTDifference
Sharpe ratioReturn per unit of total volatility

+0.62

Sortino ratioReturn per unit of downside risk

+0.87

Omega ratioGain probability vs. loss probability

1.28

1.18

+0.10

Calmar ratioReturn relative to maximum drawdown

2.59

1.38

+1.21

Martin ratioReturn relative to average drawdown

7.27

3.47

+3.80

PBE vs. VHT - Sharpe Ratio Comparison

The current PBE Sharpe Ratio is 1.63, which is higher than the VHT Sharpe Ratio of 1.00. The chart below compares the historical Sharpe Ratios of PBE and VHT, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


PBEVHTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.63

1.00

+0.62

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.14

0.30

-0.17

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.30

0.55

-0.24

Sharpe Ratio (All Time)

Calculated using the full available price history

0.32

0.56

-0.23

Drawdowns

PBE vs. VHT - Drawdown Comparison

The maximum PBE drawdown since its inception was -45.69%, which is greater than VHT's maximum drawdown of -39.12%. Use the drawdown chart below to compare losses from any high point for PBE and VHT.


Loading charts...

Drawdown Indicators


PBEVHTDifference

Max Drawdown

Largest peak-to-trough decline

-45.69%

-39.12%

-6.57%

Max Drawdown (1Y)

Largest decline over 1 year

-11.73%

-10.40%

-1.33%

Max Drawdown (3Y)

Largest decline over 3 years

-22.43%

-16.91%

-5.52%

Max Drawdown (5Y)

Largest decline over 5 years

-34.71%

-17.71%

-17.00%

Max Drawdown (10Y)

Largest decline over 10 years

-37.84%

-28.85%

-8.99%

Current Drawdown

Current decline from peak

-3.62%

-7.05%

+3.43%

Average Drawdown

Average peak-to-trough decline

-16.24%

-5.99%

-10.25%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.17%

4.14%

+0.03%

Volatility

PBE vs. VHT - Volatility Comparison

Invesco Dynamic Biotechnology & Genome ETF (PBE) has a higher volatility of 5.63% compared to Vanguard Health Care ETF (VHT) at 4.08%. This indicates that PBE's price experiences larger fluctuations and is considered to be riskier than VHT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


PBEVHTDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.63%

4.08%

+1.55%

Volatility (6M)

Calculated over the trailing 6-month period

13.27%

10.08%

+3.19%

Volatility (1Y)

Calculated over the trailing 1-year period

18.71%

14.34%

+4.37%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.54%

14.96%

+7.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.92%

16.94%

+7.98%

PBE vs. VHT - Expense Ratio Comparison

PBE has a 0.59% expense ratio, which is higher than VHT's 0.09% expense ratio.


Dividends

PBE vs. VHT - Dividend Comparison

PBE's dividend yield for the trailing twelve months is around 1.05%, less than VHT's 1.71% yield.


PositionTTM20252024202320222021202020192018201720162015
PBE
Invesco Dynamic Biotechnology & Genome ETF
1.05%1.00%0.05%0.02%0.00%0.00%0.04%0.00%0.00%0.57%0.38%1.12%
VHT
Vanguard Health Care ETF
1.71%1.61%1.53%1.36%1.33%1.14%1.21%1.89%1.38%1.31%1.45%1.22%

Frequently Asked Questions


PBE and VHT have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PBE has higher volatility (5.63%) compared to VHT (4.08%). In terms of maximum drawdown, PBE dropped -45.69% vs VHT's -39.12%.

On 10-year performance, VHT leads with 9.26% vs 7.55% for PBE. On fees, VHT is cheaper at 0.09% per year. On volatility, VHT has been the lower-risk option at 4.08%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 10-year period, VHT has performed better with a 9.26% return vs 7.55%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

VHT is cheaper with a 0.09% expense ratio, compared with 0.59% for PBE.

VHT has the higher dividend yield at 1.71%, compared with 1.05% for PBE.

PBE tracks Dynamic Biotech & Genome Intellidex Index (AMEX), while VHT tracks MSCI US Investable Market Health Care 25/50 Index. They also come from different issuers: Invesco and Vanguard. Their fees differ too: 0.59% for PBE and 0.09% for VHT.

PBE currently has the higher Sharpe Ratio (1.63 vs 1.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for PBE and VHT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer